Andrew Novick, MD, PhD
Psychiatry
Locations
Practice Locations
CU Medicine Psychiatry - Women's Behavioral Health and Wellness
303-724-1646
Helen and Arthur E. Johnson Depression Center
CU Anschutz Medical Campus
303-724-3300
Provider Expertise
Clinical Interest for Patients
My main areas of clinical focus are on 1) women's behavioral health and 2) the use of advanced pharmacological interventions, including esketamine for the treatment of Major Depressive Disorder.
Care Philosophy
I believe in providing care that: 1) Is tailored to the unique experiences and biology of the individual; 2) Is grounded in scientific evidence; 3) Promotes healthy individual development throughout the lifespan.
Specialties
- Psychiatry ( 2019 )
Conditions & Treatments
-
Women's Health
-
Mental Health and Behavior
Education & Training
Medical Schools
MD, Sanford School of Medicine The University of South Dakota (2015)
Undergraduate Schools
BS, University of the Sciences in Philadelphia (PA) (2008)
Graduate Schools
PhD, University of South Dakota, The (2015)
Residency Program
Brown University (Butler Hospital) Program (2019)
Professional Memberships
American Psychiatric Association, Member
American Society of Clinical Psychopharmacology, Member
Society of Biological Psychiatry, Member
Research & Grants
Grants
Neurobiology of Hormonal Contraception (2023)
Research Interests for Patients
My research interests are divided into two main areas: 1) Understanding the effects of sex steroids on the brain 2) Evaluating novel drug therapies for psychiatric disorders, specifically psychedelics. I am currently testing the effects of an oral birth control pill on brain functions related to mood, motivation, and pleasure. I am also principal investigator on a study evaluating the effects of the psychedelic drug, psilocybin, in treatment-resistant Major Depressive Disorder.
information for referring providers
Referral Contact Phone
(303) 724-1646
Referral Contact Fax
303-724-8859
Clinical Interests for Referring Providers
My main expertise is in the psychopharmacological management of psychiatric disorders. I have particular interest in women's behavioral health, including perinatal, postpartum and peri-menopasual psychiatric treatment. I also specialize in the use of advanced pharmacological interventions for treatment-resistant mood disorders and act as medical director of the CU Esketamine Program, which utilizes esketamine nasal spray for the treatment of Major Depressive Disorder.
Research Interest for Referring Providers
My two primary research interests are: 1) evaluating the effects of endogenous and exogenous sex steroids on brain processes related to motivation and reward; 2) evaluating the use of novel drug therapies for the treatment of psychiatric disorders, including the use of psychedelics.
